Clinical trial
Efficacy of Intra-Articular Injectable Platelet-Rich Fibrin (i-PRF) in the Treatment of Temporomandibular Joint Disorders
NCT07188974 is registered in ClinicalTrials.gov with Eskisehir Osmangazi University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intra-Articular Injectable Platelet-Rich Fibrin (i-PRF) in the Treatment of Temporomandibular Joint Disorders
- Lead sponsor
- Eskisehir Osmangazi University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 2, 2024
- Completion date
- September 16, 2025
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arthrocentesis, tmj disc disorder, treatment